Citation Impact
Citing Papers
Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors
2017
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase
2017
Bone grafts and biomaterials substitutes for bone defect repair: A review
2017 Standout
Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent
2018
Free radicals, antioxidants and functional foods: Impact on human health
2010 Standout
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Hepatocellular carcinoma
2016 Standout
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
2013
Hepatocellular carcinoma
2018 Standout
Copper, oxidative stress, and human health
2005
Mechanisms of hepatic stellate cell activation
2017 Standout
Free radicals, metals and antioxidants in oxidative stress-induced cancer
2006 Standout
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
2015
Nutritional immunity: transition metals at the pathogen–host interface
2012 Standout
Advances in metal-induced oxidative stress and human disease
2011 Standout
A Phase II Trial of Tetrathiomolybdate After Surgery for Malignant Mesothelioma: Final Results
2008
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study
2017
Copper homeostasis inEnterococcus hirae
2003
Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis
2004
Diagnosis and current therapy of Wilson's disease
2004
Copper complexes as therapeutic agents
2011
Efflux-mediated heavy metal resistance in prokaryotes
2003 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma
2016
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography - a randomised study
2013
Update on Biomarkers of Hepatocellular Carcinoma
2013
Should AFP (or Any Biomarkers) Be Used for HCC Surveillance?
2017
Pyroptosis: mechanisms and diseases
2021 Standout
Methods of assessment of iodine status in humans: a systematic review
2009 Standout
Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice
2003
Copper deficiency as an anti-cancer strategy.
2004
Wilson's disease and other neurological copper disorders
2014
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Clinical evidence for the regression of liver fibrosis
2012
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
2014
Protective effect of orally administered carnosine on bleomycin-induced lung injury
2007
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
2007 Standout
The biogenic methanobactin is an effective chelator for copper in a rat model for Wilson disease
2011
Wilson disease in children
2017
Anticopper therapy against cancer and diseases of inflammation and fibrosis
2005
The cytotoxicity of the anticancer drug elesclomol is due to oxidative stress indirectly mediated through its complex with Cu(II)
2014
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
2018
Superoxide dismutases and their impact upon human health
2005
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
2015
Surveillance for hepatocellular carcinoma
2016
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma
2013
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
2015
Hepatocellular carcinoma
2022 Standout
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Hepatocellular Carcinoma
2019 Standout
Copper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson's Disease
2001
Copper and Its Complexes in Medicine: A Biochemical Approach
2011
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
2019
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis
2016
Metallodrugs in Medicinal Inorganic Chemistry
2014
Advances in Treatment of Wilson Disease
2017
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Wilson disease
2003
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Metallic Copper as an Antimicrobial Surface
2010 Standout
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
2015
Oral antiviral therapy improves the diagnostic accuracy of alpha‐fetoprotein levels in patients with chronic hepatitis B
2014
Diffusion‐weighted MRI for hepatocellular carcinoma screening in chronic liver disease: Direct comparison with ultrasound screening
2016
Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm
2009
Heavy Metals and Pesticides Toxicity in Agricultural Soil and Plants: Ecological Risks and Human Health Implications
2021 Standout
Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies
2011
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Copper-related diseases: From chemistry to molecular pathology
2009
An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis
2016
Pathogenesis and management ofW ilson disease
2014
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
2000
Re‐evaluation of the indications for liver transplantation in W ilson's disease based on the outcomes of patients referred to a transplant center
2013
Works of Fred Askari being referenced
Treatment of Wilson's disease with tetrathiomolybdate: V. control of free copper by tetrathiomolybdate and a comparison with trientine
2009
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate
2006
Wilson's disease: clinical management and therapy
2004
Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial
2009
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate
2003
Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc
2003
WTX101 in patients newly diagnosed with Wilson disease: final results of a global, prospective phase 2 trial
2017
Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
2012
Tetrathiomolybdate Therapy Protects Against Concanavalin a and Carbon Tetrachloride Hepatic Damage in Mice
2004